NCT00004915View on ClinicalTrials.gov

Raloxifene in Treating Patients With Persistent or Recurrent Endometrial Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

November 30, 1998

Primary Completion Date

February 29, 2000

Study Completion Date

February 29, 2000

Conditions
Endometrial Cancer
Interventions
DRUG

raloxifene

Trial Locations (1)

60611

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Northwestern University

OTHER

NCT00004915 - Raloxifene in Treating Patients With Persistent or Recurrent Endometrial Cancer | Biotech Hunter | Biotech Hunter